njh395
NON-breast HER2+ Malignancies
Novartis PharmaceuticalsPhase 1
—
Rating in progress
njh395 in NON-breast HER2+ Malignancies is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant